PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
08-Oct-2025 AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors AlphaMedixTM (
08-Oct-2025 Portzamparc – BNP Paribas Group Initiates Coverage of ONWARD Medical with a Buy Rating and Target Price of EUR 10.20 Portzamparc
08-Oct-2025 Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds Microbot Medical
07-Oct-2025 CluePoints Proven AI Innovation Earns Dual Recognition at SCDM and SCRIP Awards CluePoints
07-Oct-2025 TrialAssure Introduces Enhanced Architectural Techniques to Improve Accuracy, Visibility, Traceability, and Control Across its AI Platform for Pharma and Biotech TrialAssure
07-Oct-2025 Theolytics Appoints Experienced Medical Oncologist Matilde Saggese, MD, as Chief Medical Officer Theolytics
07-Oct-2025 Resolution Therapeutics to present EMERALD study design at the British Association for the Study of the Liver (BASL) annual meeting 2025 Resolution Therapeutics
07-Oct-2025 appoints industry veteran Philippe Monteyne as chairman as it accelerates late-stage development of breakthrough stroke candidate Bioxodes
06-Oct-2025 Transgene to Present New Immunological Data from Phase I Trial of Individualized Therapeutic Cancer Vaccine, TG4050, at SITC 2025 Transgene
06-Oct-2025 Promising results for Lead Biologics’ first-in-class checkpoint inhibitor published in Nature Cancer Lead Biologics
06-Oct-2025 Hikma and Celltrion strengthen partnership to expand biosimilar access in MENA Hikma
06-Oct-2025 Enara Bio to Reveal DARKFOX, a Novel Cancer-Specific Dark Antigen with Broad-Ranging Therapeutic Potential, in Oral Presentation at SITC 2025 Enara Bio
06-Oct-2025 EG 427 Receives U.S. FDA Fast Track Designation for EG110A DNA Medicine in Neurogenic Bladder Patients EG 427
05-Oct-2025 Freelance Clinical Invites Vendors to Claim Platform Early Access Freelance Clinical
03-Oct-2025 Santhera Announces Approval in Canada for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy Santhera
03-Oct-2025 Igyxos Biotherapeutics Awarded EUR 5.7 Million from the French Government to Accelerate Development of its First-in-class Monoclonal Antibody for the Treatment of Infertility Igyxos Biotherapeutics
03-Oct-2025 Landmark report warns food systems breach planetary limits  www.uea.ac.uk.  
03-Oct-2025 Cambridge’s Papworth Hospital Pilots Steriwave The Royal Papworth Hospital NHS Foundation Trust,
02-Oct-2025 MMS Announces Its Role in Supporting Gates Ventures and the GNPC to Deliver One of the World's Largest Proteomic Datasets for Neurodegenerative Diseases MMS
02-Oct-2025 Tessellate Bio Appoints Katie Chapman as Chief Scientific Officer Tessellate Bio